St. Michael's Hospital, Toronto (Canada)
Member of:
Event: ESC Congress 2022
Topic: Pharmacotherapy
Session: Lipid-lowering therapy and the atheroma
Event: ESC Congress 2020
Topic: Prevention
Session: PCSK9 inhibitors from bench to real world: a journey to improve CV outcomes in very high-risk patients
Event: ESC Congress 2020
Topic: Treatment
Session: Coronary Artery Disease (Chronic) ePosters
Event: ESC Congress 2018
Topic: Treatment
Session: Identifying patients who may benefit most from PCSK9i: highlights from the latest ODYSSEY OUTCOMES data
Event: ESC Congress 2016
Topic: Thrombosis and platelets
Session: Dual antiplatelet therapy: the long and the short of it!
Event: ESC CONGRESS 2014
Topic: Primary cardiovascular prevention: interventions and outcomes
Session: New frontiers in cholesterol management in high cardiovascular risk patients